NCT01784081撤回不适用
iPC3 - Integrating Palliative Care and Modern Palliative Care Tools Into the Care of Patients With Pancreas Cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 试验地点
- 1
- 主要终点
- Feasibility of the patients with metastatic pancreas cancer to meet with the palliative care team and to complete symptom assessments.
研究概览
简要总结
The main purpose of this study is to evaluate the acceptance by patients with metastatic pancreas cancer of integrating palliative care with usual cancer treatment. Palliative care intervention will involve use of pancreas cancer-specific decision aides (iPC3)about prognosis, treatment choices, and advance care planning for patients facing a treatment decision as well as symptom assessments. We hypothesize that palliative care consultations with iPC3 will be accepted, symptoms can be diminished, information can be received in a way that improves choices, and that the quality of care can be improved.
详细描述
- Each patient undergoing treatment at Johns Hopkins for metastatic pancreas cancer will receive palliative care support during their course to include: palliative care consultation early in their treatment course; patient decision aids that give survival, treatment benefits and risks; suggestions to complete such tasks as advance directives, durable power of medical attorney, wills, family and spiritual reviews as recommend by the American Society of Clinical Oncology; and when indicated, transition to hospice.
- Patient will have an iPad for their visit, and a corresponding website to print information.
- Each patient will assess their distress with the Distress thermometer; symptoms with the Condensed Memorial Symptom Assessment Scale and a depression screen. This information will be given to the health care practitioner before the patient visit.
- Patients facing a treatment decision will receive a Patient Information Program link (or paper for those unable to work on the iPad) to review the diagnosis, prognosis, specific benefits and risks with the proposed chemotherapy. This will then give transition "prompts" to encourage thinking about advance directives, durable power of medical attorney, use of hospice, and doing a life review.
- We will also offer a hospice information visit when patient has - in the projection of the team or treating physician - 3 to 6 months to live.
- The palliative care team will meet at least monthly with each of the enrolled patients.
- Participants will be followed for as long as he or she is alive before receiving hospice care.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •All patients with metastatic pancreas cancer will be eligible, ages 18 and above.
- •There is no limit to the amount of prior therapy for metastatic disease.
- •Ability to understand and the willingness to sign a written informed consent document and to answer a questionnaire.
- •English speakers.
排除标准
- •Patients who have tumors other than metastatic pancreas cancer.
- •Patients who actively decline participation or who are judged to be in distress before the interview.
- •Patients who are pregnant.
结局指标
主要结局
Feasibility of the patients with metastatic pancreas cancer to meet with the palliative care team and to complete symptom assessments.
时间窗: participants will be followed monthly until referred to hospice or until death, an expected average of 1 year
次要结局
- Changes in hospice referral, use, acceptance, and length of stay, compared to similar patients in the prior 12 months (from retrospective review)(1 year)
- Changes in symptoms listed in the Memorial Symptom Assessment Scale (condensed version)(participants will be followed monthly until referred to hospice or until death, an expected average of 1 year)
- Changes in the use of wills, living wills, advanced medical directives, durable power of medical attorney and preferred place of death.(1 year)
研究者
研究点 (1)
Loading locations...
相似试验
撤回
不适用
Palliative Care in Improving Quality of Life and Symptoms in Patients With Stage III-IV Pancreatic or Ovarian CancerRecurrent Ovarian Epithelial CancerRecurrent Ovarian Germ Cell TumorRecurrent Pancreatic CancerStage III Pancreatic CancerStage IIIA Ovarian Epithelial CancerStage IIIA Ovarian Germ Cell TumorStage IIIB Ovarian Epithelial CancerStage IIIB Ovarian Germ Cell TumorStage IIIC Ovarian Epithelial CancerStage IIIC Ovarian Germ Cell TumorStage IV Ovarian Epithelial CancerStage IV Ovarian Germ Cell TumorStage IV Pancreatic CancerNCT01927393City of Hope Medical Center
已完成
不适用
Early Palliative Care in Pancreatic Cancer - a Quasi-experimental StudyPancreatic CancerNCT04290364Inge Høgh Dufva74
招募中
不适用
Study of PRO in Patients With Advanced Pancreatic or Biliary Tract Cancer (BetterEveryDay)Lung Cancer, Nonsmall CellPancreatic CancerNCT04611867Inna Chen, MD274
Unknown
不适用
Integration of Palliative Care in an Oncology and Hematology UnitAdvanced CancerNCT04089306University Hospital, Strasbourg, France100
进行中（未招募）
不适用
Early Palliative Care for Patients With Advanced Pancreatic Cancer.Pancreatic CancerNCT04632303Inna Chen, MD250